Medreich Limited Atorvastatin Export Data — India (DGFT 2022–2026)

Name: Medreich Limited Atorvastatin Export Records India — #10 Exporter, 291 Shipments, $14.6M FOB USD (DGFT 2022–2026)
Creator: TransData Nexus
Published: 2026-05-01T00:00:00Z
License: https://transdatanexus.com/terms-and-conditions

Suresh Sormare

Atorvastatin

India Pharmaceutical Trade Intelligence

$1.1B477 Suppliers145 CountriesHS 30049099

ExportsIndia → UNITED STATES52.5%India → CANADA25.9%

ImportsCROATIA → India$3.5M CANADA → India$2.5M

#1 Supplier: INTAS PHARMACEUTICALS #1 Buyer: APOTEX CORP

Medreich Limited — Atorvastatin Exporter #10 | $14.6M Trade Value | TransData Nexus | TransData Nexus

Medreich Limited — Atorvastatin Exporter Profile

Indian Pharmaceutical Exporter · #10 for Atorvastatin · $14.6M export value · DGFT Verified

Medreich Limited is the #10 Indian exporter of Atorvastatin with $14.6M in export value and 291 verified shipments. Medreich Limited holds a 1.3% market share in Atorvastatin exports across 6 countries. The company exports 42 pharmaceutical products worth $224.8M across 15 therapeutic categories.

Medreich Limited — Atorvastatin Export Profile: Buyers & Destinations

Medreich Limited Atorvastatin export treemap — buyers and destination countries | TransData Nexus

Where Does Medreich Limited Export Atorvastatin?

Country	Value	Shipments	Share
JAPAN	$4.9M	112	60.1%
CANADA	$2.8M	246	34.4%
UNITED KINGDOM	$412.8K	24	5.0%
OMAN	$35.7K	6	0.4%

Who Are the Top Buyers of Atorvastatin from Medreich Limited?

Buyer	Country	Value	Orders
JAMP PHARMA CORPORATION	CANADA	$2.8M	246
MEIJI SEIKA PHARMATECH CO., LTD	JAPAN	$2.3M	53
MEIJI SEIKA PHARMA CO.LTD, ODAWARA	JAPAN	$750.0K	15
MEIJI SEIKA PHARMATECH CO LTD	JAPAN	$750.0K	15
MEIJI SEIKA PHARMATECH CO LIMITED	JAPAN	$690.0K	16
MEDREICH PLC	UNITED KINGDOM	$412.8K	24
MEIJI SEIKA PHARMATECH CO. LIMITED	JAPAN	$258.4K	6
MEIJI SEIKA PHARMA CO LTD ODAWARA	JAPAN	$200.0K	4
PHILEX PHARMACEUTICALS	OMAN	$35.7K	6
BYNOV MEDICAL COMPANY LTD	SUDAN	$2.6K	1

Medreich Limited supplies Atorvastatin to 13 buyers globally. The largest buyer is JAMP PHARMA CORPORATION (CANADA), followed by MEIJI SEIKA PHARMATECH CO., LTD (JAPAN) and MEIJI SEIKA PHARMA CO.LTD, ODAWARA (JAPAN). These buyers represent pharmaceutical distributors, hospital groups, and government procurement agencies in their respective markets.

What Atorvastatin Formulations Does Medreich Limited Export?

Product Description / Formulation	Value	Shipments
ATORVASTATIN TABLETS 5MG (ATORVASTATIN T	$550.0K	11
ATORVASTATIN TABLETS 10MG ATORVASTATIN	$439.9K	9
ATORVASTATIN TABLETS 10MG (ATORVASTATIN	$400.0K	8
ATORVASTATIN 20MG FILM COATED TABLETS (J	$221.0K	11
ATORVASTATIN 80MG FILM COATED TABLETS (JAMP ATORVASTATIN 80MG TABLETS) 100S (8582 PACKS )	$208.3K	5
ATORVASTATIN 40MG FILM COATED TABLETS (J	$170.5K	5
ATORVASTATIN TABLETS 5MG ATORVASTATIN TABLETS 5MG MEIJI PO NO MM 154 PACK SIZE 69444S QTY 159 578	$150.0K	3
ATORVASTATIN TABLETS 10MG ATORVASTATINTABLETS 10MG MEIJI PO NO MM 153 PACKSIZE 56818 NO QTY 163 294	$150.0K	3
ATORVASTATIN TABLETS 10MG P.O NO. MM-164 DTD 21.07.2023 PACK SIZE:56818 NO QTY:150.672NOS	$150.0K	3
ATORVASTATIN TABLETS 5MG , PACK SIZE:69444S , QTY:159.185	$150.0K	3

Medreich Limited exports 209 distinct Atorvastatin formulations including tablets, capsules, syrups, and combination drugs. The top formulation is ATORVASTATIN TABLETS 5MG (ATORVASTATIN T with 11 shipments worth $550.0K.

How Does Medreich Limited Compare to Nearest Atorvastatin Exporters?

Exporters ranked immediately above and below #10 by export value

#	Supplier	Export Value	Shipments	Countries	Avg/Shipment
3	MYLAN LABORATORIES LIMITED	$16.5M	330	7	$50.0K
1	INTAS PHARMACEUTICALS LIMITED	$16.4M	328	10	$50.0K
10	MEDREICH LIMITED ★	$14.6M	291	6	$50.0K
5	ALKEM LABORATORIES LIMITED	$13.8M	277	5	$50.0K
11	MICRO LABS LIMITED	$13.7M	413	22	$33.2K

Medreich Limited ranks #10 among 477 Indian Atorvastatin exporters. Average shipment value of $50.0K compared to the market average of $657.7K. The closest competitors by value are MYLAN LABORATORIES LIMITED and INTAS PHARMACEUTICALS LIMITED.

Which Indian Ports Ship Atorvastatin Exports?

Port	Shipments	% Share
HYDERABAD ICD	2,042	13.6%
HYDERABAD ICD (INSNF6)	1,131	7.5%
NHAVA SHEVA SEA (INNSA1)	842	5.6%
SAHAR AIR	839	5.6%
JNPT/ NHAVA SHEVA SEA	779	5.2%
DELHI AIR	613	4.1%
SAHAR AIR CARGO ACC (INBOM4)	581	3.9%
HYDERABAD AIR	554	3.7%

Geopolitical & Trade Policy Impact on Medreich Limited's Atorvastatin Exports

The current geopolitical climate presents both challenges and opportunities for Indian pharmaceutical exporters like Medreich Limited. The Israel-Iran tensions have led to disruptions in Red Sea shipping routes, resulting in increased shipping costs and extended transit times. Major shipping lines have implemented 'Emergency Risk Surcharges' ranging from $250 to $500 per TEU, directly impacting the cost structures of exporters relying on these routes. (sgeexport.com)

Conversely, the US-China trade tensions have prompted the United States to seek alternative sources for pharmaceuticals, potentially benefiting Indian exporters. However, the imposition of tariffs on pharmaceutical imports by the US poses a risk to Indian companies, as higher tariffs could render low-margin generic drugs unprofitable, leading to market exits and exacerbating drug shortages in the US. (cfo.economictimes.indiatimes.com)

The recent India-European Union Free Trade Agreement (FTA), signed in January 2026, offers a favorable development for Medreich. The FTA eliminates tariffs on Indian pharmaceutical products entering the EU, providing immediate cost relief and enhancing market access. This agreement is expected to significantly boost India's pharmaceutical exports to Europe, creating new opportunities for companies like Medreich to expand their presence in the EU market. (en.wikipedia.org)

Medreich Limited — Regulatory Compliance & Quality Standards

Compliance with international regulatory standards is paramount for Indian pharmaceutical exporters. The US Food and Drug Administration (FDA), World Health Organization (WHO), and European Union Good Manufacturing Practices (EU GMP) set stringent quality requirements that companies must adhere to for market access. Recent regulatory frameworks have increased compliance costs by an average of 18.7%, leading to a 15.2% reduction in export volumes to the US in the first quarter of 2025. (transdatanexus.com)

For Medreich Limited, maintaining compliance with these evolving standards is crucial to sustaining and expanding its export markets. Investments in quality assurance, regular audits, and staying abreast of regulatory changes are essential strategies to navigate this complex landscape.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Analysis Methodology

1.Product Matching: Atorvastatin shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature.
2.Supplier Identification: Medreich Limited matched across shipments using name normalization, accounting for company name formatting variations.
3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.
4.Verified Records: This page is backed by 393 individual customs records matching Medreich Limited exporting Atorvastatin, covering 209 formulations to 6 countries via 13 buyers.

Government-Sourced Data

Official DGFT customs records

Transparent Methodology

Calculations fully disclosed above

Global Coverage

Exports to 145+ countries, 1,291+ buyers

Expert-Reviewed

Analyzed by pharmaceutical trade specialists

Atorvastatin

Atorvastatin

Medreich Limited — Atorvastatin Exporter Profile

Medreich Limited — Atorvastatin Export Profile: Buyers & Destinations

Where Does Medreich Limited Export Atorvastatin?

Who Are the Top Buyers of Atorvastatin from Medreich Limited?

What Is India's Total Atorvastatin Export Value and How Much Does Medreich Limited Contribute?

What Is the Average Shipment Value for Medreich Limited's Atorvastatin Exports?

How Does Medreich Limited Compare to Other Indian Atorvastatin Exporters?

What Atorvastatin Formulations Does Medreich Limited Export?

Regulatory Requirements: Exporting Atorvastatin to Key Markets

Japan — PMDA

Canada — HC

United Kingdom — MHRA

How Does Medreich Limited Compare to Nearest Atorvastatin Exporters?

Which Indian Ports Ship Atorvastatin Exports?

What Other Cardiovascular Products Does Medreich Limited Export?

Geopolitical & Trade Policy Impact on Medreich Limited's Atorvastatin Exports

Medreich Limited — Regulatory Compliance & Quality Standards

About Medreich Limited

Market Intelligence

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

Analysis Methodology

Get Atorvastatin Export Data from Medreich Limited

Atorvastatin Stats

Company Overview

Top Products by Medreich Limited

Related Analysis

Need Detailed Export Data?

Data Source